Abstract
The Coronavirus pandemic, Covid-19 and SARS-Cov-2 put multidisciplinary research by chemists, biologists, pharmacists and theorists necessary and primordial task to find new active biomolecules which will be beneficial for all humanity. The azoles drugs are electronic rich, they should be used with caution, and an understanding of their pharmacokinetic profile, safety, absorption, distribution, excretion, metabolism, toxicity, and drug-drug interaction profiles is important to provide effective and cure therapy. In these objectives and goals, twenty aromatic nitrogen heterocycle compounds were chosen for in silico, docking and AMET studies against SARS-CoV-2. In this paper with respect to the protein S of SARS-CoV-2 properties, the GAUSSIAN 09w program used in the semi-empirical method at the AM1 level with the optimization of the geometry of the structures. Then Toxicity and physicochemical properties were evaluated by AMET. Molecular docking investigations conducted; the binding affinities as well as interactions of the sieve compounds with the SRAS-CoV-2 protein Spike using PyRx software. In general, the preliminary results are fructuous and needs further in vitro testes.
Keywords: Pyrazole, Imidazole, Triazole, SARS-CoV-2, Theoretical study, AMET
1. Introduction
The theoretical calculation of bonding energy is important. It helps to screen the formulations to avoid many unnecessary lab reactions; eventually, it can save the chemical and time. Thus, it is highly beneficial for the environment by using only necessary chemicals as well as cost-effective by arranging the required chemicals only. The widely used theoretical calculation method of bonding is the density functional the (DFT) method. Especially, the hydrogen bond energy calculation by the DFT method has been proved an efficient tool [1], [2], [3], [4], [5], [6], [7], [8], [9], [10]. The Nitrogen chemistry containing multimodal molecules is attracting current interest in the scientific world because of their specificity for biological targets [11]. These azole compounds are also appeared to play a key role since it is involved in several types of chelating ligands [12], [13], [14], [15], [16], which have been used in models that mimic the active sites of copper proteins [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45]. Meanwhile, research into the properties of nitrogen ligand complexes has increased exponentially [46], largely due to their possible use as photo-catalysts during solar energy conversion, anti-inflammatory agents [47], cytotoxic agents [48], insecticides [49], herbicides [50], fungicides [51]. Aromatic nitrogen heterocyclic compounds and their derivatives represent an important class in metal coordination chemistry [52]. These complexes have been extensively studied generating increasing interest in coordination chemistry and medicinal chemistry [53]. In fact, several derivatives have been successfully prepared and marketed such as Celecoxib, Viagra, Rimonabant, Sulfaphenazole or Penthiopyrad (Fig. 1 ) [54].
Fig. 1.
Usual drug basis in pyrazole.
Our study focuses on pyrazole, thiazole and imidazole derivate (Fig. 2 ) by evaluating their biological activity and interaction on SARS-CoV-2 protein Spike.
Fig. 2.
Structure of 20 monodentate compounds based on pyrazole, triazole and imidazole.
2. Materials and methods
2.1. Chemistry
We first undertook the synthesis of 1-hydroxymethyl-3, 5-dimethylpyrazole and 1-hydroxymethyl-pyrazole by the condensation of 3, 5-dimethylpyrazole with formaldehyde in aqueous solution (37 %), the same technique used for imidazole and triazole.
2.2. Theoretical calculations
Theoretical calculations evaluated using Gaussian 09w and Gaussview09 for optimization, Osiris for the toxicity risk of the molecules while Molinspiration calculates the physicochemical properties. The sieves compounds will be evaluated with ADMETlab.2.0 to determinate the ADMET properties before Docking in protein spike 6CS2. Molecular docking studies were performed by using Vina in PyRx docking tool to predict the protein–ligand interactions at molecular level. The crystal structure of COVID-19 main protease (6CS2) was used as targets. Target proteins were downloaded from Protein Data Bank and prepared by Biovia discovery studio tool. The water molecules were removed and polar hydrogens were added to the protein. The ligand molecules and protein structures determined were imported into PyRx and converted into PDBQT format. The active sites of target molecules were identified from the existing ligand molecules in crystal structures. The docking simulations were performed after assigning grid box and grid centers in Vina wizard. The docking results were visualized by using Biovia Discovery Studio Visualizer.
3. Results and discussions
3.1. Lipinski rules
Lipinski's Rule of Five, also known as Pfizer's Rule of Five or simply the Rule of Five, is a basic rule for evaluating drug-likeness or determining whether a chemical compound with a certain pharmacological or biological activity has chemical properties and physical properties that would make it an orally active drug in humans [55] (Table 1 ).
Table 1.
Lipinski’s rule of the twenty compounds.
|
Lipinski rules |
Toxicity risk |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Code | MW(g/mol) | NHBA | NHBD | Log(P) | V | Mu | Tu | Ir | Re |
| 1 | 68.08 | 2 | 1 | 0.32 | None | --- | --- | --- | +++ |
| 2 | 96.13 | 2 | 1 | 0.76 | None | --- | +++ | --- | --- |
| 3 | 158.20 | 2 | 1 | 2.21 | None | --- | --- | --- | --- |
| 4 | 220.28 | 2 | 1 | 3.67 | None | --- | --- | --- | --- |
| 5 | 68.08 | 2 | 1 | −0.07 | None | +++ | --- | --- | +++ |
| 6 | 154.17 | 4 | 1 | 0.99 | None | --- | +++ | --- | --- |
| 7 | 140.14 | 4 | 1 | 0.61 | None | --- | +++ | --- | --- |
| 8 | 126.11 | 4 | 2 | 0.35 | None | --- | +++ | --- | --- |
| 9 | 156.10 | 6 | 3 | −0.06 | None | --- | --- | --- | --- |
| 10 | 69.07 | 3 | 1 | −0.61 | None | --- | --- | +++ | --- |
| 11 | 98.11 | 3 | 1 | −0.65 | None | --- | +++ | +++ | +++ |
| 12 | 126.16 | 3 | 1 | 0.18 | None | --- | +++ | +++ | +++ |
| 13 | 188.23 | 3 | 1 | 1.64 | None | --- | +++ | +++ | +++ |
| 14 | 250.30 | 3 | 1 | 3.09 | None | --- | +++ | +++ | +++ |
| 15 | 98.11 | 3 | 1 | −0.65 | None | --- | +++ | +++ | +++ |
| 16 | 184.20 | 5 | 1 | 0.41 | None | --- | +++ | +++ | +++ |
| 17 | 170.17 | 5 | 1 | 0.04 | None | --- | +++ | +++ | +++ |
| 18 | 156.14 | 5 | 2 | −0.23 | None | --- | +++ | +++ | +++ |
| 19 | 186.12 | 7 | 3 | −0.64 | None | --- | +++ | +++ | +++ |
| 20 | 99.09 | 4 | 1 | −1.19 | None | --- | +++ | +++ | +++ |
With (MW: Molecular weight; NHBA: Number of Hydrogen Bond Acceptors; NHBD: Number of Hydrogen Bond Donners; Log (P): water/octanol partition coefficient, it measures the lipophilic character: V: Violation;
Mu: Mutagenic; Tu: Tumorigenic; Ir: Irritant; Re: Reproduction effective).
Lipinski rules used for the screening of molecules in order to eliminate molecules that may cause problems of absorption, bioavailability and eventual toxicity on the human body. The rule describes molecular properties important for the pharmacokinetics of a drug in the human body, including its absorption, distribution, metabolism, excretion and toxicity (“ADME-Tox”). No compound violates Lipinski’s rule, so none seem to cause absorption or solubility problems. However, this result does not mean that these molecules are active. The molecules that haven reproductive mutagenic and tumorigenic effects not consider such as a therapeutic compound. Three compounds (3, 4, and 9) among twenty do not present any risk of toxicity to humans. This allows us to concentrate the effort of our work in only in these three compounds.
3.2. Geometry optimization:
The structures modelized and geometry optimized using the semi-empirical method at the le AM1 level with Gaussian 09w and Gausview 6.0.16 in the gas phase. The energy level of HOMO and LUMO determined. The HOMO (highest occupied molecular orbital) and LUMO (lowest occupied molecular orbital) of the frontier molecular orbital’s (FMOs) play a key role in the reactivity of the molecular. Table 2 shows the HOMO And LUMO orbital molecular for the twenty following compounds.
Table 2.
Molecular orbital's of the twenty structures.
| Code | Structure | HOMO | LUMO |
|---|---|---|---|
| 1 | ![]() |
![]() |
![]() |
| 2 | ![]() |
![]() |
![]() |
| 3 | ![]() |
![]() |
![]() |
| 4 | ![]() |
![]() |
![]() |
| 5 | ![]() |
![]() |
![]() |
| 6 | ![]() |
![]() |
![]() |
| 7 | ![]() |
![]() |
![]() |
| 8 | ![]() |
![]() |
![]() |
| 9 | ![]() |
![]() |
![]() |
| 10 | ![]() |
![]() |
![]() |
| 11 | ![]() |
![]() |
![]() |
| 12 | ![]() |
![]() |
![]() |
| 13 | ![]() |
![]() |
![]() |
| 14 | ![]() |
![]() |
![]() |
| 15 | ![]() |
![]() |
![]() |
| 16 | ![]() |
![]() |
![]() |
| 17 | ![]() |
![]() |
![]() |
| 18 | ![]() |
![]() |
![]() |
| 19 | ![]() |
![]() |
![]() |
| 20 | ![]() |
![]() |
![]() |
The ionization potential, electron affinity, global hardness, chemical potential, electrophilicity index, hardness and softness values reported (atomic units) in Table 3 .
Table 3.
Values of chemical reactivity of the twenty compounds.
| Code | EHOMO | ELUMO | ΔE | η | σ | χ | µ | ω |
|---|---|---|---|---|---|---|---|---|
| 1 | −0.3567 | 0.3508 | 0.7075 | 0.35375 | 2.82685512 | 0.00295 | −0.00295 | 0.0000123004 |
| 2 | −0.34179 | 0.3479 | 0.68969 | 0.344845 | 2.89985356 | −0.00306 | 0.003055 | 0.0000135322 |
| 3 | −0.32047 | 0.00625 | 0.32672 | 0.16336 | 6.12144956 | 0.15711 | −0.15711 | 0.0755495596 |
| 4 | −0.31997 | −0.01217 | 0.3078 | 0.1539 | 6.4977258 | 0.16607 | −0.16607 | 0.0896011855 |
| 5 | −0.36333 | 0.0025 | 0.36583 | 0,0.182915 | 5.4670202 | 0.180415 | −0.18042 | 0.0889745844 |
| 6 | −0.39544 | −0.02871 | 0.36673 | 0.183365 | 5.45360347 | 0.212075 | −0.21208 | 0.1226401048 |
| 7 | −0.36088 | 0.00603 | 0.36691 | 0.183455 | 5.45092802 | 0.177425 | −0.17743 | 0.0857966003 |
| 8 | −0.36005 | 0.00726 | 0.36731 | 0.183655 | 5.44499197 | 0.176395 | −0.1764 | 0.0847109962 |
| 9 | −0.37748 | 0.01986 | 0.39734 | 0.19867 | 5.03347259 | 0.17881 | −0.17881 | 0.0804676501 |
| 10 | −0.3366 | 0.03588 | 0.37248 | 0.18624 | 5.36941581 | 0.15036 | −0.15036 | 0.0606962242 |
| 11 | −0.34723 | 0.03691 | 0.38414 | 0.19207 | 5.20643515 | 0.15516 | −0.15516 | 0.0626714885 |
| 12 | −0.33633 | 0.03652 | 0.37285 | 0.186425 | 5.36408743 | 0.149905 | −0.14991 | 0.0602695696 |
| 13 | −0.33834 | −0.00539 | 0.33295 | 0.166475 | 6.00690794 | 0.171865 | −0.17187 | 0.0887147566 |
| 14 | −0.32535 | −0.00426 | 0.32109 | 0.160545 | 6.22878321 | 0.164805 | −0.16481 | 0.0845890187 |
| 15 | −0.33946 | 0.02793 | 0.36739 | 0.183695 | 5.44380631 | 0.155765 | −0.15577 | 0.0660408156 |
| 16 | −0.35919 | 0.00377 | 0.36296 | 0.18148 | 5.51024906 | 0.17771 | −0.17771 | 0.0870091583 |
| 17 | −0.35256 | 0.00775 | 0.36031 | 0.180155 | 5.55077572 | 0.172405 | −0.17241 | 0.0824941967 |
| 18 | −0.35481 | 0.00445 | 0.35926 | 0.17963 | 5.56699883 | 0.17518 | −0.17518 | 0.0854201202 |
| 19 | −0.38897 | −0.03262 | 0.35635 | 0.178175 | 5.61245966 | 0.210795 | −0.2108 | 0.1246935093 |
| 20 | −0.37759 | 0.01416 | 0.39175 | 0.195875 | 5.10529675 | 0.181715 | −0.18172 | 0.0842893203 |
3.3. Energy MEP
The molecular electrostatic potential (MEP) is used globally as a reactivity map displaying the most suitable region for the electrophilic and nucleophilic attack of charged point-like reagents on organic molecules. It helps to illustrate the biological recognition process and hydrogen bonding interaction. the energy MEP also used to visualize the reactivity area in molecule. It’s informed the reaction may be haven with our molecules. The richest electronegativity shown by the red color in the molecular map (Fig. 3 ).
Fig. 3.
The MEP map of the compounds 3, 9 and 4.
The importance of MEP lies in the fact that it simultaneously shows the molecular size and shape, as well as positive, negative and neutral electrostatic potential regions in terms of color grading, which is very useful in the research of molecular structure, along with the physicochemical properties’ relationship. Molecular electrostatic potential (MEP) was calculated to forecast the reactive sites for the. electrophilic and nucleophilic attack of the optimized structure of electrostatic potential are represented by different colors, with potential increases in the order red < orange < yellow < green < blue. The red color displays the maximum negative area, which shows favorable sites for electrophilic attack; the blue color indicates the maximum positive area favorable for the nucleophilic attack, and the green color represents zero potential areas.
3.4. Molecular docking and simulation
Molecular docking is a type of bioinformatics modeling which deals with the interaction between two or more molecules to give a stable adduct. The key aim of molecular docking is to predict the potential binding geometries of a putative ligand of a known three-dimensional structure with a target protein. In this investigation, three molecular based on pyrazole were studied in silico to highlight their possible binding energy and interaction modes with the active site of SARS-CoV-2 main protease (Fig. 4 ), using the AutoDock Vina software. Then this three moleculars conduced to molecular docking study withe the proteine spike viral 6CS2. The molecular 9 illustred very interesting interaction with the proteine spike with the litle distance between ligand-proteine.
Fig. 4.
Molecular docking interaction modes with SARS-CoV-2 main protease with compounds 3, 4 and 9.
The distance of the ligands, along with the change in the accessible area of the two important catalytic residues (Cys145 and His41) within the active site of the protease, is shown in Fig. 4. It is noted that the analyzed of the active site of the main protease of SARS-CoV-2, like the standard drug hydroxychloroquine (HCQ), which is inevitable to prevent the protein mutarotation of the virus by minimizing the viral replication. The binding affinities calculated varied in the range of (-4.0 to − 8.6 kcal/mol), suggesting that the synthesized molecules can spontaneously interact within the binding site of the SARS-CoV-2 main protease.
Although the blind docking studies revealed that all the molecules can act as potential agents for the establishment of COVID-19 drugs, from the estimated free energy of binding values, it may be inferred that the analogs (3, 4 and 9) with the highest negative minimum binding energy value amongst all the studied analogs could be the best possible SARS-CoV-2 inhibitors.
4. Conclusion
In this research, a series of ligands based on pyrazole analogs were analyzed in silico for their molecular docking, and drug likeness properties. In addition, these analogs were analyzed for their cytotoxicity and pharmacokinetic properties, which revealed that a combination of toxicity determination, in silico ADMET prediction, and drug-likeness has promising results because most of the designed molecules showed improved kinetic parameters, and maintained all drug-likeness rules as well as provided an interesting result in terms of biological activity. Most of the ligand’s pyrazole analogs have a HOMO-LUMO gap lower than pyrazole. pyrazole analogs (3, 4 and 9) showed promising binding interactions and binding energy with SARS-CoV-2 main protease which revealed analogs (3, 4 and 9) showed an in silico potent ability to fight SARS-CoV-2. The molecular electrostatic potential study also showed the most negative and positive surface area of the investigated ligand, and thus, anticipated the most suitable areas for hydrogen bonding sites.
CRediT authorship contribution statement
Mounir Mohamed: Conceptualization, Methodology, Validation, Formal analysis, Data curation, Writing – original draft. Farid Abrigach: Data curation, Methodology, Supervision. Sghir El Kadiri: Conceptualization, Methodology, Supervision. Said Omar Said Hassane: Resources, Validation, Supervision. Magda H. Abdellattif: Formal analysis, Supervision, Validation. Rachid Touzani: Conceptualization, Investigation, Supervision.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
I would like to thank the Laboratory of Applied Chemistry and Environment (LCAE) of the Faculty of Sciences of Oujda, for providing a laboratory equipment. I would also like to thank the CNRST-Rabat for its analytical support and the IRC of Italy. Bilateral project between CNR Italy and CNRST Morocco (project 2020/2022, CUP B54I20000340001, IC-CNR Bari, Italy, A.M., and UMP Oujda, Morocco, R.T.).
Data availability
No data was used for the research described in the article.
References
- 1.Kaddouri Y., Bouchal B., Abrigach F., El Kodadi M., Bellaoui M., Elkamhawy A., Touzani R., Abdellattif M.H. New N-alkylated heterocyclic compounds as prospective NDM1 inhibitors: investigation of in vitro and in silico properties. Pharmaceuticals. 2022;15(7):803. doi: 10.3390/ph15070803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Y. Kaddouri, R. Benabbes, S. Ouahhoud, M.H. Abdellattif, B. Hammouti, R. Touzani , An Insight into All Tested Small Molecules against Fusarium oxysporum f. sp. Albedinis: A Comparative Review Molecules 27(9) (2022) 2698;https://doi.org/10.3390/molecules27092698. [DOI] [PMC free article] [PubMed]
- 3.Kaddouri Y., Bouchal B., Abrigach F., El Kodadi M., Bellaoui M., Touzani R., Mitu L. Synthesis, molecular docking, MEP and SAR analysis, ADME-Tox predictions, and antimicrobial evaluation of novel mono-and tetra-alkylated pyrazole and triazole ligands. J. Chem. 2021;2021:1–11. doi: 10.1155/2021/6663245. [DOI] [Google Scholar]
- 4.Kaddouri Y., Abrigach F., Yousfi E.B., Hammouti B., El Kodadi M., Alsalme A., Al-Zaqri N., Warad I., Touzani R. New heterocyclic compounds: synthesis, antioxidant activity and computational insights of nano-antioxidant as ascorbate peroxidase inhibitor by various cyclodextrins as drug systems. Curr. Drug Delivery. 2021;18(3):334–349. doi: 10.2174/1567201817999201001205627. [DOI] [PubMed] [Google Scholar]
- 5.Hadda T.B., Rastija V., Almalki F.A., Titi A., Touzani R., Mabkhot Y.N., Khalid S., Zarrouk A., Siddiqui B.S. Petra/Osiris/molinspiration and molecular docking analyses of 3-hydroxy-indolin-2-one derivatives as potential antiviral agents. Curr. Comput.-Aided Drug Design. 2021;17(1):123–133. doi: 10.2174/1573409916666191226110029. [DOI] [PubMed] [Google Scholar]
- 6.Bhat A.R., Dongre R.S., Almalki F.A., Berredjem M., Aissaoui M., Touzani R., Hadda T.B., Akhter M.S. Synthesis, biological activity and POM/DFT/docking analyses of annulated pyrano [2, 3-d] pyrimidine derivatives: identification of antibacterial and antitumor pharmacophore sites. Bioorg. Chem. 2021;106 doi: 10.1016/j.bioorg.2020.104480. [DOI] [PubMed] [Google Scholar]
- 7.Y. Kaddouri, F.Abrigach, S. Ouahhoud, R. Benabbes, M. El Kodadi, A. Alsalme, N. Al-Zaqri, I. Warad, R. Touzani, Mono-Alkylated Ligands Based on Pyrazole and Triazole Derivatives Tested Against Fusarium oxysporum f. sp. albedinis: Synthesis, Characterization, DFT, and Phytase Binding Site Identification Using Blind Docking/ Virtual Screening for Potent Fophy Inhibitors, Frontiers in chemistry 8 (2020) 559262. https://doi.org/10.3389/fchem.2020.559262. [DOI] [PMC free article] [PubMed]
- 8.Titi A., Almutairi S.M., Alrefaei A.F., Manoharadas S., Alqurashy B.A., Sahu P.K., Hammouti B., Touzani R., Messali M., Ali I. Novel phenethylimidazolium based ionic liquids: design, microwave synthesis, in-silico, modeling and biological evaluation studies. J. Mol. Liq. 2020;315 doi: 10.1016/j.molliq.2020.113778. [DOI] [Google Scholar]
- 9.Titi A., Messali M., Alqurashy B.A., Touzani R., Shiga T., Oshio H., Fettouhi M., Rajabi M., Almalki F.A., Hadda T.B. Synthesis, characterization, X-Ray crystal study and bioctivities of pyrazole derivatives: identification of antitumor, antifungal and antibacterial pharmacophore sites. J. Mol. Struc. 2020;1205 doi: 10.1016/j.molstruc.2019.127625. [DOI] [Google Scholar]
- 10.Touzani R., Hammouti B., El Malki F., Benhadda T. Coronavirus, Covid19, Covid-19 and SARS-Cov-2: a global pandemic, a Short Review. J. Mater. Environ. Sci. 2020;11(5):736–750. [Google Scholar]
- 11.W. Kaim and B. Schwederski, BioInorganic Chemistry Inorganic Elements in the Chemistry of Life, An Introduction and Guide, John Wiley & Sons, 2006 (ISBN: 978-0-470-97523-7).
- 12.Sorrell T.N., Vankai V.A., Garrity M.L. Synthesis and reactivity of dinuclear copper complexes having a m-xylyl spacer between coordination units. Inorg. Chem. 1991;30(2):207–210. doi: 10.1021/ic00002a013. [DOI] [Google Scholar]
- 13.S. Gross, D. Breuninger, H. Bastiaans, W. V. Deyn, M. Puhl, K. K, D. Anspaugh, D. Culbertson and H. Oloumi-Sadeghi, “Pyrazole compounds fopr controlling invertebrate pests.,” PCT Int. Appl., p. 135, 2009.
- 14.Bruno O., Schenone S., Ranise A., Bondavalli F., Filippelli W., Falcone G., Motola G., Mazzeo F. Antiinflammatory agents: new series of N-substituted amino acids with complex pyrimidine structures endowed with antiphlogistic activity. Il Farmaco. 1999;5:95–100. doi: 10.1016/s0014-827x(98)00109-8. [DOI] [PubMed] [Google Scholar]
- 15.Kumar M., Aran V., Navarro P., Ramos-Gallardo A., Vegas A. Dinuclear Cu(II) complexes with two pyrazolate bridging groups formed from 26-membered oxaimine and polyamine macrocycles of 3,5-disubstituted 1H-pyrazole. Tetrahedron Lett. 1994;35:5723–5726. doi: 10.1016/S0040-4039(00)77289-3. [DOI] [Google Scholar]
- 16.D. Chou, W. Knauf, M. Maier, F. Lochhaas and K. Seeger, “Preparation of pyrazole derivative pesticides.,” US Pat. Appl. Publ., p. 24, 2007.
- 17.Kaddouri Y., Haddari H., Titi A., Yousfi E.B., Chetouani A., El Kodadi M., Touzani R. Catecholase catalytic properties of copper (II) complexes prepared in situ with heterocyclic ligands: experimental and DFT study. Mor. J. Chem. 2020;8(1):184–196. doi: 10.48317/IMIST.PRSM/morjchemv8i1.16657. [DOI] [Google Scholar]
- 18.Titi A., Oshio H., Touzani R., Alsalme A., Warad I. Synthesis and XRD of novel Ni4(l3-O)4 twist cubane cluster using three NNO mixed ligands: hirshfeld, spectral, thermal and oxidation properties. J. Cluster Sci. 2020 doi: 10.1007/s10876-020-01780-0. [DOI] [Google Scholar]
- 19.Boulemche H., Anak B., Djedouani A., Touzani R., François M., Fleutot S., Rabilloud F. Synthesis, X-ray crystallography, computational studies and catecholase activity of new zwitterionic Schiff base derivatives. J. Mol. Stru. 2019;1178:606–616. doi: 10.1016/j.molstruc.2018.10.078. [DOI] [Google Scholar]
- 20.Boyaala R., Touzani R., Roisnel T., Dorcet V., Caytan E., Jacquemin D., Boixel J., Guerchais V., Doucet H., Soulé J.-F. Catalyst-controlled regiodivergent C-H arylation site of fluorinated 2-arylpyridine derivatives: application to luminescent iridium(III) complexes. ACS Catal. 2019;9(2):1320–1328. doi: 10.1021/acscatal.8b04553. [DOI] [Google Scholar]
- 21.Titi A., Al-Noaimi M., Kaddouri Y., El Ati R., Yousfi E.B., El Kodadi M., Touzani R. Study of the catecholase catalytic properties of copper (II) complexes prepared in-situ with monodentate ligands. Mater. Today: Proc. 2019;13:1134–1142. doi: 10.1016/j.matpr.2019.04.081. [DOI] [Google Scholar]
- 22.El Ati R., Takfaoui A., El Kodadi M., Touzani R., Yousfi E.B., Almalki F.A., Hadda T.B. Catechol oxidase and copper(I/II) complexes derived from bipyrazol ligand: synthesis, molecular structure investigation of new biomimetic functional model and mechanistic study. Mater. Today: Proc. 2019;13:1229–1237. doi: 10.1016/j.matpr.2019.04.092. [DOI] [Google Scholar]
- 23.N. Bouroumane, M. El Kodadi, R. Touzani, A. Oussaid, Catechol oxidase activity: from 2000 to 2019: mini review, Arab. J. Chem. Environ. Res. 06 (2019) 94–111.
- 24.Benzai A., Derridj F., El Ati R., El Kodadi M., Touzani R., Ben Hadda T., Doucet H. Studies of catecholase activities of N-donor bidentates ligands derivated from benzoxazole with copper (II) salts. Mor. J. Chem. 2009;7(2):401–409. doi: 10.48317/IMIST.PRSM/morjchem-v7i2.16075. [DOI] [Google Scholar]
- 25.Boyaala R., El Ati R., Khoutoul M., El Kodadi M., Touzani R., Hammouti B. Biomimetic oxidation of catechol employing complexes formed in situ with heterocyclic ligands and different copper(II) salts. J. Iran. Chem. Soc. 2018;15(1):85–92. doi: 10.1007/s13738-017-1211-0. [DOI] [Google Scholar]
- 26.Bouanane Z., Bounekhel M., Elkolli M., Abrigach F., Khoutoul M., Bouyala R., Touzani R., Hellal A. Synthesis, structural, catecholase, tyrosinase and DFT studies of pyrazoloquinoxaline derivatives. J. Mol. Struc. 2017;1139:238–246. doi: 10.1016/j.molstruc.2017.03.052. [DOI] [Google Scholar]
- 27.Boyaala R., Touzani R., Guerchais V., Soulé J.-F., Doucet H. Synthesis of 2-(fluorinated aryl)pyridine derivatives via palladium-catalyzed C-H bond arylation of fluorobenzenes using 2-halopyridines as aryl sources. Tetrahedron Lett. 2017;58(33):3205–3208. doi: 10.1016/j.tetlet.2017.06.075. [DOI] [Google Scholar]
- 28.Jahier C., Touzani R., El Kadiri S., Nlate S. Enantiopure 24-armed dendritic polyoxometalates: synthesis and evaluation as recoverable catalysts for asymmetric sulfide oxidation. Inorg. Chim. Acta. 2016;450:81–86. doi: 10.1016/j.ica.2016.05.019. [DOI] [Google Scholar]
- 29.Mouadili A., Chtita S., El Ouafi A., Bouachrine M., Zarrouk A., Touzani R. Biomimetic catecholase activities by prepared in-situ complexes: development of a quantitative structure-properties relationship (QSPR) J. Mat. Enviro. Sci. 2016;7(1):210–221. [Google Scholar]
- 30.Djedouani A., Abrigach F., Khoutoul M., Mohamadou A., Bendaas A., Oussaid A., Touzani R. Catecholase activity investigations using in situ copper complexes continuing schiff base derivatives with atheoretical calculation. Oriental J. Chem. 2015;31(1):97–105. [Google Scholar]
- 31.Thabti S., Djedouani A., Rahmouni S., Touzani R., Bendaas A., Mousser H., Mousser A. Synthesis, X-ray crystal structures and catecholase activity investigation of new chalcone ligands. J. Mol. Stru. 2015;1102:295–301. doi: 10.1016/j.molstruc.2015.08.071. [DOI] [Google Scholar]
- 32.Mouadili A., El Ouafi A., Attayibat A., Radi S., Touzani R. Catecholase and tyrosinase biomimetic activities for heteroatom donor ligands: influence of five parameters. J. Mat. Enviro. Sci. 2015;6(8):2166–2173. [Google Scholar]
- 33.Takfaoui A., Touzani R., Soulé J.-F., Dixneuf P.H., Doucet H. Palladiumcatalysed direct arylation using free-amine-substituted polyfluoroanilines with inhibition of amination-type reaction. Asian J. Org. Chem. 2015;4(10):1085–1095. doi: 10.1002/ajoc.201500268. [DOI] [Google Scholar]
- 34.Takfaoui A., Lamsayah M., El Ouafi A., Oussaid A., Kabouche Z., Touzani R. N, N’-bipyrazole compounds: effect of concentration, solvent, ligand and metal anions on the catecholase properties. J. Mat. Enviro. Sci. 2015;6(8):2129–2136. [Google Scholar]
- 35.Mouadili A., Al-blewi F.F., Rezki N., Messali M., El Ouafi A., Touzani R. Biomimetic catecholase studies: Using in-situ prepared complexes by 1,2,4- triazole schiff bases and different metal salts. J. Mat. Enviro. Sci. 2015;6(9):2392–2399. [Google Scholar]
- 36.Belfilali I., Louhibi S., Mahboub R., Touzani R., El Kadiri S., Roisnel T. Study of the histamine copper(II) chloride complex catalytic activity. Res. Chem. Intermediates. 2015;41(3):1819–1831. [Google Scholar]
- 37.Takfaoui A., Zhao L., Touzani R., Soulé J.-F., Dixneuf P.H., Doucet H. One pot Pd (OAc)2-catalysed 2,5-diarylation of imidazoles derivatives. Tetrahedron. 2014;70(44):8316–8323. doi: 10.1016/j.tet.2014.09.012. [DOI] [Google Scholar]
- 38.A. Takfaoui, L. Zhao, R. Touzani, P.H. Dixneuf, H. Doucet, Palladium-catalysed direct diarylations of pyrazoles with aryl bromides: a one step access to 4,5- diarylpyrazoles, Tetrahedron Lett. 55 (10) (2014) 1697–1701, https://doi.org/ 10.1016/j.tetlet.2014.01.079.
- 39.Takfaoui A., Lakehal I., Bouabdallah I., Halaimia F., Nacer H., Hammouti B., Touzani R. New imines bearing alkyl armed for catecholase activity. J. Mat. Enviro. Sci. 2014;5(3):753–756. [Google Scholar]
- 40.Mouadili A., Lakehal I., Takfaoui A., Halaimia F., Nacer H., Hamlaoui M.L., Hammouti B., Messali M., Touzani R. Air oxidation of catechol by in-situ copper (II) complexes with ligands containing benzyl groups. J. Mat. Enviro. Sci. 2014;5(3):715–722. [Google Scholar]
- 41.Mouadili A., Attayibat A., Radi S., Touzani R. Catecholase activity studies of two multidendate ligands based on pyrazole. Arab. J. Chem. Environ. Res. 2014;01:24–32. [Google Scholar]
- 42.Touzani R. Hydroformylation reaction of styrene using new rhodium pyrazole complex. Arab. J. Chem. Environ. Res. 2014;01:76–99. [Google Scholar]
- 43.Mouadili A., Attayibat A., Kadiri S.E., Radi S., Touzani R. Catecholase activity investigations using in situ copper complexes with pyrazole and pyridine based ligands. Appl. Catal. A: General. 2013;454:93–99. doi: 10.1016/j.apcata.2013.01.011. [DOI] [Google Scholar]
- 44.Toubi Y., Touzani R., Radi S., El Kadiri S. Synthesis, characterization and catecholase activity of copper (II) complexes with bispyrazole tri-podal ligands. J. Mat. Enviro. Sci. 2012;3(2):328–341. [Google Scholar]
- 45.Mouadili A., Zerrouki A., Herrag L., Hammouti B., Kadiri S.E., Touzani R. Catechol oxidation: activity studies using electron rich nitrogen based ligands. Res. Chem. Intermediates. 2012;38(9):2427–2433. doi: 10.1007/s11164-012-0558-1. [DOI] [Google Scholar]
- 46.S. Schnatterer, G. Heubach, J. Tiebes, W. Knauf, M. Kern and U. Sanft, “Preparation of 1-aryl-4-(carbonyl derivative)pyrazole pesticides.,” Ger. Offen, (1996) 52.
- 47.U. Jensen-Korte, R. Gehring, O. Schallner, J. Stetter, B. W. H. Becker, B. Homeyer, W. Behrenz, S. Wilhelm and P. Andrews, “Preparation of pyrazole pesticides,” Ger. Offen, p. (1986) 142.
- 48.Karim C., Sebbar N., Kheira K.K., Mokhtar E. Etude des proprietés complexante des derivés du pyrazole et du benzamidazole vis à vis des metaux. Mar. Chim. Heterocycl. 2018;17:1. [Google Scholar]
- 49.StarcevicK K., Ester M., Karminski-Zamola G. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorg. Med. Chem. 2007;15:4419–4426. doi: 10.1016/j.bmc.2007.04.032. [DOI] [PubMed] [Google Scholar]
- 50.Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001:1–3. doi: 10.1016/s0169-409x(00)00129-0. [DOI] [PubMed] [Google Scholar]
- 51.Chen C., Chang W., Sheu S., Lee G., Ho T., Lin Y., Wang Y. Synthesis and molecular structure of novel zinc(II) complexes: [{Zn(HL)Cl2}n], [Zn2L2Cl2] and [Zn2(μ-OH)LCl2][HL = 4-methyl-2,6-bis(pyrazol-1-ylmethyl)phenol] J. Chem. Soc. 1991:1569–1573. doi: 10.1039/DT9910001569. [DOI] [Google Scholar]
- 52.Pate J., Cruse R., Karlin K., Solomon E. Vibrational, electronic, and resonance Raman spectral studies of [Cu2(YXL-O-)O2]+, a copper(II) peroxide model complex of oxyhemocyanin. J. Am. Chem. Soc. 1987;109:2624–2630. doi: 10.1021/ja00243a013. [DOI] [Google Scholar]
- 53.Nelson S., Esho F., Lavery A., Drew M. Dicopper complexes of a macrocyclic ligand as models for type 3 copper proteins. J. Am. Chem. Soc. 1983;105:5693–5695. doi: 10.1021/ja00355a031. [DOI] [Google Scholar]
- 54.Sorrell T., Jameson D., O’Connor C. Synthesis, structure and magnetic properties of a binuclear, pentacoordinate copper(II)complex. Inorg. Chem. 1984;23:190–195. doi: 10.1021/ic00170a015. [DOI] [Google Scholar]
- 55.Jamwal A., Javed A., Bhardwaj V. A review on Pyrazole derivatives of pharmacological potential. J. Pharm. BioSci. 2013;1(3):114–123. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No data was used for the research described in the article.

































































